Discover, in the October 2026 DermaVet Journal Club, the analysis of the 57 latest publications from around the world in canine and feline dermatology, read one by one: what they bring and their limitations. So you don’t miss any of the latest developments in our field.
Key takeaways this month
57publications analyzed
8topics
The October 2026 review focuses mainly on atopic dermatitis, antibiotic stewardship, chronic otitis and parasitic diseases. Two placebo-controlled trials show that fecal microbiota transplantation, added to usual treatment, and oral baicalin reduce the lesions of canine atopic dermatitis. Transplantation also reduces the need for symptomatic medication. The diagnosis of food allergy still relies on an elimination diet followed by oral challenge, because a systematic review finds no test able to replace it.
Allergy also plays a part in infections: in diabetic patients, pyoderma is almost always accompanied by another disease, most often allergic dermatitis. To treat these infections, chlorhexidine remains active against staphylococci that are nonetheless multidrug-resistant, which supports topical treatment. In acute otitis, Nordic practitioners almost always give antibiotics topically when they prescribe them.
When otitis becomes chronic or recurs, its cause should be sought: a fibroepithelial polyp to remove endoscopically, Aspergillus or a dermatophyte to culture, or Malassezia with reduced susceptibility to miconazole.
Finally, two doses of oral lotilaner one month apart eliminate Lynxacarus radovskyi in cats, and a single dose of afoxolaner treats Cordylobia anthropophaga myiasis in dogs.
To read the full analysis of these articles, and of all those not covered in this summary, click the button below.
Find all issues on the DermaVet Journal Club page.